PHOTOCURE ASA
看多
已更新

Photocure $PHO.OL stock pullback after Q2 is chance to buy

189
Photocure $PHO.OL PHO presented Q2 2019 numbers today, with most numbers landing very close to expectations.

Webcast: https://webtv.hegnar.no/presentation.php?webcastId=98041425

Press release: https://newsweb.oslobors.no/message/482310

Armchair Healthcare podcast interview with CEO Dan Schneider: https://twitter.com/MaxJacobsEdison/status/1151116879089586176


交易進行
Trade very much active after two analyst BUY recommendations this week:
Edison, target price NOK 69.
Norne securities, target price NOK 64.

At the current shareprice of NOK 53 this represents a reasonable upside potential.
交易進行
Trade still active, coming into a crucial phase where either a stop or new upwards movement can be triggered
交易進行
With crucial Q3 presentation coming up, PHO still trades within clearly defined trading range.

Nice update from company today:
photocure.com/news/siu2019_athens/
交易結束:目標達成
Safe choice is to end this trade today before Photocure Q3 presentation, as the stock has been known to make some drastic biotech sell the news moves.

We can note a nice 49 to 59 NOK swing on this trade.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。